These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 16115477
1. Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging. Sirol M, Aguinaldo JG, Graham PB, Weisskoff R, Lauffer R, Mizsei G, Chereshnev I, Fallon JT, Reis E, Fuster V, Toussaint JF, Fayad ZA. Atherosclerosis; 2005 Sep; 182(1):79-85. PubMed ID: 16115477 [Abstract] [Full Text] [Related]
2. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent. Sirol M, Fuster V, Badimon JJ, Fallon JT, Moreno PR, Toussaint JF, Fayad ZA. Circulation; 2005 Sep 13; 112(11):1594-600. PubMed ID: 16145001 [Abstract] [Full Text] [Related]
3. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Botnar RM, Perez AS, Witte S, Wiethoff AJ, Laredo J, Hamilton J, Quist W, Parsons EC, Vaidya A, Kolodziej A, Barrett JA, Graham PB, Weisskoff RM, Manning WJ, Johnstone MT. Circulation; 2004 Apr 27; 109(16):2023-9. PubMed ID: 15066940 [Abstract] [Full Text] [Related]
4. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Botnar RM, Buecker A, Wiethoff AJ, Parsons EC, Katoh M, Katsimaglis G, Weisskoff RM, Lauffer RB, Graham PB, Gunther RW, Manning WJ, Spuentrup E. Circulation; 2004 Sep 14; 110(11):1463-6. PubMed ID: 15238457 [Abstract] [Full Text] [Related]
5. Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility. Vymazal J, Spuentrup E, Cardenas-Molina G, Wiethoff AJ, Hartmann MG, Caravan P, Parsons EC. Invest Radiol; 2009 Nov 14; 44(11):697-704. PubMed ID: 19809344 [Abstract] [Full Text] [Related]
10. Monovalent and bivalent fibrin-specific MRI contrast agents for detection of thrombus. Nair SA, Kolodziej AF, Bhole G, Greenfield MT, McMurry TJ, Caravan P. Angew Chem Int Ed Engl; 2008 May 14; 47(26):4918-21. PubMed ID: 18496805 [No Abstract] [Full Text] [Related]
11. Molecular magnetic resonance imaging allows the detection of activated platelets in a new mouse model of coronary artery thrombosis. Duerschmied D, Meißner M, Peter K, Neudorfer I, Roming F, Zirlik A, Bode C, von Elverfeldt D, von Zur Muhlen C. Invest Radiol; 2011 Oct 14; 46(10):618-23. PubMed ID: 21577120 [Abstract] [Full Text] [Related]
12. Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent. Spuentrup E, Katoh M, Wiethoff AJ, Parsons EC, Botnar RM, Mahnken AH, Günther RW, Buecker A. Am J Respir Crit Care Med; 2005 Aug 15; 172(4):494-500. PubMed ID: 15937292 [Abstract] [Full Text] [Related]
13. Fibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis. Andia ME, Saha P, Jenkins J, Modarai B, Wiethoff AJ, Phinikaridou A, Grover SP, Patel AS, Schaeffter T, Smith A, Botnar RM. Arterioscler Thromb Vasc Biol; 2014 Jun 15; 34(6):1193-1198. PubMed ID: 24723557 [Abstract] [Full Text] [Related]
14. In vivo assessment of intraplaque and endothelial fibrin in ApoE(-/-) mice by molecular MRI. Makowski MR, Forbes SC, Blume U, Warley A, Jansen CH, Schuster A, Wiethoff AJ, Botnar RM. Atherosclerosis; 2012 May 15; 222(1):43-9. PubMed ID: 22284956 [Abstract] [Full Text] [Related]